Skip to main content

GROUPAMA ASSET MANAGMENT

Position in DNLI — Denali Therapeutics Inc.

CIK 1055969 PARIS, I0

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,914,031
+$1,937,135 QoQ
Shares Held
229,939
+11.0% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#57
of 290 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GROUPAMA ASSET MANAGMENT holds $277,486,304 across 10 Biotechnology names. DNLI ranks #8 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 DNLI
Denali Therapeutics Inc.
This page
229,939 $5,914,031

All Filings in DNLI

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,914,031 229,939
2026-03-31 $3,976,896 207,130
2025-12-31 $2,502,767 151,591
2025-09-30 $1,971,206 135,758
2025-06-30 $2,455,678 175,531
2025-03-31 $1,964,314 144,488
2024-12-31 $2,246,018 110,207
2024-09-30 $2,273,450 78,045
2024-06-30 $1,680,849 72,388
2024-03-31 $899,330 43,827
2023-12-31 $751,378 35,013